CME Group (CME)
(Delayed Data from NSDQ)
$222.04 USD
+0.87 (0.39%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $222.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$222.04 USD
+0.87 (0.39%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $222.04 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Zacks News
Cboe Global (CBOE) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Cboe Global (CBOE) Q1 results reflect higher net transaction and clearing fees, access and capacity fees, and market data, offset by higher expenses.
CME Group (CME) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CME Group (CME) Q1 results reflect higher revenues and lower expenses.
CME Group (CME) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 5.50% and 2.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why CME Group (CME) Might Surprise This Earnings Season
by Zacks Equity Research
CME Group (CME) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why CME (CME) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is a Beat in the Cards for CME Group (CME) in Q1 Earnings?
by Zacks Equity Research
CME Group's (CME) first-quarter performance is likely to have been aided by higher clearing, transaction fees and other revenues, market data and information services and lower expenses.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess have been highlighted in this Industry Outlook article.
5 Securities and Exchanges in Focus Despite Industry Headwinds
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) Beats on Q1 Earnings, Tweaks Expense View
by Zacks Equity Research
Nasdaq's (NDAQ) Q1 performance reflect solid results at the Solutions segment.
CME Group (CME) Unveils Micro-Sized Bitcoin and Ether Options
by Zacks Equity Research
CME Group (CME) introduces Micro Bitcoin and Micro Ether futures to add to the existing suite of cryptocurrency derivative offerings.
CME Group (CME) Gains 8% YTD: Can it Maintain the Upside?
by Zacks Equity Research
Compelling derivative product lines, global presence, a growing proportion of volume from customers outside the United States, focus on over-the-counter clearing services and effective capital deployment continue to drive CME Group (CME).
The Zacks Analyst Blog Highlights Exxon Mobil, Wells Fargo, CME Group, JPMorgan Chase, and AmerisourceBergen
by Zacks Equity Research
Exxon Mobil, Wells Fargo, CME Group, JPMorgan Chase, and AmerisourceBergen are part of today's Analyst blog.
Top Research Reports for Exxon Mobil, Wells Fargo & CME Group
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including Exxon Mobil Corporation (XOM), Wells Fargo & Company (WFC) and CME Group Inc. (CME).
CME (CME) Down 6.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Company News for Feb 10, 2022
by Zacks Equity Research
Companies in The News Are: CME,CHEF,FOXA,CMG
CME Group (CME) Q4 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
CME Group (CME) Q4 results reflect higher clearing and transaction fees and market data and information services. Average daily volume increased in three out of the six products lines.
CME Group (CME) Q4 Earnings Top Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 1.22% and 2.23%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for CME Group (CME)
by Zacks Equity Research
CME Group (CME) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why CME (CME) Could Beat Earnings Estimates Again
by Zacks Equity Research
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CBOE Global (CBOE) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
CBOE (CBOE) delivered earnings and revenue surprises of 11.11% and 0.85%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for CME Group (CME) in Q4 Earnings?
by Zacks Equity Research
CME Group's (CME) fourth-quarter performance is likely to have been aided increased trading activity and lower costs.
IntercontinentalExchange (ICE) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
ICE (ICE) delivered earnings and revenue surprises of 1.52% and 1.16%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq's (NDAQ) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nasdaq's (NDAQ) Q4 results reflect growth in Market Services, Corporate Platforms, Investment Intelligence and Market Technology segments.